News
MTNB
0.1988
+8.93%
0.0163
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 2d ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 2d ago
Why Webull Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga · 2d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 3d ago
Matinas BioPharma Has Received A Notice Of Allowance For A U.S. Patent Titled "ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS".
Benzinga · 3d ago
Weekly Report: what happened at MTNB last week (0810-0814)?
Weekly Report · 5d ago
Weekly Report: what happened at MTNB last week (0803-0807)?
Weekly Report · 08/10 10:18
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 08/07 21:05
Weekly Report: what happened at MTNB last week (0727-0731)?
Weekly Report · 08/03 10:17
GH Power announces TKMS selected as preferred supplier for CPSP
TipRanks · 07/30 12:20
GH Power, Partnering With Matinas BioPharma, Confirms Government Of Canada Selects TKMS As Preferred Supplier For Canadian Patrol Submarine Project
Benzinga · 07/30 12:12
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 07/27 21:06
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 07/27 17:06
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 07/27 12:05
Weekly Report: what happened at MTNB last week (0720-0724)?
Weekly Report · 07/27 10:22
Why Forte Biosciences Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket
Benzinga · 07/27 09:09
Matinas BioPharma Ends At-The-Market Sales Agreement
TipRanks · 07/24 21:34
BTIG Terminates Sales Agreement With Matinas BioPharma, Effective Immediately On July 23; Incurs No Termination Penalties Or Expenses From Sales Agreement Termination
Benzinga · 07/24 21:11
Weekly Report: what happened at MTNB last week (0713-0717)?
Weekly Report · 07/20 10:18
Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data
NASDAQ · 07/18 05:19
More
Webull provides a variety of real-time MTNB stock news. You can receive the latest news about Matinas Biopharm through multiple platforms. This information may help you make smarter investment decisions.
About MTNB
Matinas BioPharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on delivering therapies using its lipid nanocrystal (LNC) platform delivery technology. Its lead product candidate is MAT2203 (oral amphotericin B), a highly potent antifungal drug which, by virtue of LNC delivery, has been made oral, safe, and well-tolerated for prolonged administration in patients with life-threatening invasive fungal infections. MAT2203 has completed a Phase II encochleated oral amphotericin for cryptococcal meningitis trial (EnACT) study in HIV patients suffering from cryptococcal meningitis, meeting its primary endpoint and achieving robust survival. MAT2203 is now positioned for a single, Phase III registration trial (the ORALTO trial) in support of a New Drug Application (NDA) for the treatment of invasive aspergillosis in patients with limited treatment options.